Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer

DSpace/Manakin Repository

Search OPUS


Advanced Search

Browse

My Account

Show simple item record

dc.contributor.author King, MT
dc.contributor.author Viney, R
dc.contributor.author Smith, DP
dc.contributor.author Hossain, I
dc.contributor.author Street, D
dc.contributor.author Savage, E
dc.contributor.author Fowler, S
dc.contributor.author Berry, MP
dc.contributor.author Stockler, M
dc.contributor.author Cozzi, P
dc.contributor.author Stricker, P
dc.contributor.author Ward, J
dc.contributor.author Armstrong, BK
dc.date.accessioned 2012-10-12T03:34:55Z
dc.date.issued 2012-02-14
dc.identifier.citation BRITISH JOURNAL OF CANCER, 2012, 106 (4), pp. 638 - 645 (8)
dc.identifier.issn 0007-0920
dc.identifier.other C1 en_US
dc.identifier.uri http://hdl.handle.net/10453/18819
dc.language English
dc.publisher NATURE PUBLISHING GROUP
dc.relation.isbasedon 10.1038/bjc.2011.552
dc.subject Science & Technology, Life Sciences & Biomedicine, Oncology, ONCOLOGY, prostate cancer, preferences, trade-off, utility, survival benefit, quality of life, QUALITY-OF-LIFE, EARLY BREAST-CANCER, PATIENTS PREFERENCES, HEALTH STATES, PATIENT PREFERENCES, CHOICE EXPERIMENTS, DECISION-MAKING, OUTCOMES, UTILITIES, RADIOTHERAPY, preferences, prostate cancer, quality of life, survival benefit, trade-off, utility, prostate cancer, preferences, trade-off, utility, survival benefit, quality of life, Humans, Prostatic Neoplasms, Urologic Diseases, Androgen Antagonists, Disease-Free Survival, Prostatectomy, Radiotherapy, Aged, Intestinal Diseases, Erectile Dysfunction, Patient Preference, Middle Aged, Quality of Life, Male, Aged, Androgen Antagonists, Disease-Free Survival, Erectile Dysfunction, Humans, Intestinal Diseases, Male, Middle Aged, Patient Preference, Prostatectomy, Prostatic Neoplasms, Quality of Life, Radiotherapy, Urologic Diseases, preferences, prostate cancer, quality of life, survival benefit, trade-off, utility, Oncology & Carcinogenesis
dc.subject Science & Technology; Life Sciences & Biomedicine; Oncology; ONCOLOGY; prostate cancer; preferences; trade-off; utility; survival benefit; quality of life; QUALITY-OF-LIFE; EARLY BREAST-CANCER; PATIENTS PREFERENCES; HEALTH STATES; PATIENT PREFERENCES; CHOICE EXPERIMENTS; DECISION-MAKING; OUTCOMES; UTILITIES; RADIOTHERAPY; preferences; prostate cancer; quality of life; survival benefit; trade-off; utility; prostate cancer; preferences; trade-off; utility; survival benefit; quality of life; Humans; Prostatic Neoplasms; Urologic Diseases; Androgen Antagonists; Disease-Free Survival; Prostatectomy; Radiotherapy; Aged; Intestinal Diseases; Erectile Dysfunction; Patient Preference; Middle Aged; Quality of Life; Male; Aged; Androgen Antagonists; Disease-Free Survival; Erectile Dysfunction; Humans; Intestinal Diseases; Male; Middle Aged; Patient Preference; Prostatectomy; Prostatic Neoplasms; Quality of Life; Radiotherapy; Urologic Diseases; preferences; prostate cancer; quality of life; survival benefit; trade-off; utility; Oncology & Carcinogenesis
dc.title Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer
dc.type Journal Article
dc.description.version Published
dc.description.version Published
dc.description.version Published
dc.description.version Published
dc.description.version Published
dc.description.version Published
dc.parent BRITISH JOURNAL OF CANCER
dc.journal.volume 4
dc.journal.volume 106
dc.journal.number 4 en_US
dc.publocation London, UK en_US
dc.identifier.startpage 638 en_US
dc.identifier.endpage 645 en_US
dc.cauo.name BUS.Faculty of Business en_US
dc.conference Verified OK en_US
dc.for 140208 Health Economics
dc.personcode 0000071665 en_US
dc.personcode 020117 en_US
dc.personcode 0000071667 en_US
dc.personcode 031002 en_US
dc.personcode 950324 en_US
dc.personcode 020120 en_US
dc.personcode 0000022432 en_US
dc.personcode 944572 en_US
dc.personcode STOCM en_US
dc.personcode 0000059271 en_US
dc.personcode 0000032246 en_US
dc.personcode 0000071671 en_US
dc.personcode 0000036135 en_US
dc.percentage 100 en_US
dc.classification.name Health Economics en_US
dc.classification.type FOR-08 en_US
dc.edition en_US
dc.custom en_US
dc.date.activity en_US
dc.location.activity en_US
dc.description.keywords preferences; prostate cancer; quality of life; survival benefit; trade-off; utility en_US
dc.description.keywords Formal contract, legal fees, opportunism, relational contract, vertical relationship
dc.description.keywords Science & Technology
dc.description.keywords Science & Technology
dc.description.keywords Life Sciences & Biomedicine
dc.description.keywords Life Sciences & Biomedicine
dc.description.keywords Oncology
dc.description.keywords Oncology
dc.description.keywords ONCOLOGY
dc.description.keywords ONCOLOGY
dc.description.keywords prostate cancer
dc.description.keywords prostate cancer
dc.description.keywords preferences
dc.description.keywords preferences
dc.description.keywords trade-off
dc.description.keywords trade-off
dc.description.keywords utility
dc.description.keywords utility
dc.description.keywords survival benefit
dc.description.keywords survival benefit
dc.description.keywords quality of life
dc.description.keywords quality of life
dc.description.keywords QUALITY-OF-LIFE
dc.description.keywords QUALITY-OF-LIFE
dc.description.keywords EARLY BREAST-CANCER
dc.description.keywords EARLY BREAST-CANCER
dc.description.keywords PATIENTS PREFERENCES
dc.description.keywords PATIENTS PREFERENCES
dc.description.keywords HEALTH STATES
dc.description.keywords HEALTH STATES
dc.description.keywords PATIENT PREFERENCES
dc.description.keywords PATIENT PREFERENCES
dc.description.keywords CHOICE EXPERIMENTS
dc.description.keywords CHOICE EXPERIMENTS
dc.description.keywords DECISION-MAKING
dc.description.keywords DECISION-MAKING
dc.description.keywords OUTCOMES
dc.description.keywords OUTCOMES
dc.description.keywords UTILITIES
dc.description.keywords UTILITIES
dc.description.keywords RADIOTHERAPY
dc.description.keywords RADIOTHERAPY
dc.description.keywords Science & Technology
dc.description.keywords Life Sciences & Biomedicine
dc.description.keywords Oncology
dc.description.keywords ONCOLOGY
dc.description.keywords prostate cancer
dc.description.keywords preferences
dc.description.keywords trade-off
dc.description.keywords utility
dc.description.keywords survival benefit
dc.description.keywords quality of life
dc.description.keywords QUALITY-OF-LIFE
dc.description.keywords EARLY BREAST-CANCER
dc.description.keywords PATIENTS PREFERENCES
dc.description.keywords HEALTH STATES
dc.description.keywords PATIENT PREFERENCES
dc.description.keywords CHOICE EXPERIMENTS
dc.description.keywords DECISION-MAKING
dc.description.keywords OUTCOMES
dc.description.keywords UTILITIES
dc.description.keywords RADIOTHERAPY
dc.description.keywords Science & Technology
dc.description.keywords Life Sciences & Biomedicine
dc.description.keywords Oncology
dc.description.keywords ONCOLOGY
dc.description.keywords prostate cancer
dc.description.keywords preferences
dc.description.keywords trade-off
dc.description.keywords utility
dc.description.keywords survival benefit
dc.description.keywords quality of life
dc.description.keywords QUALITY-OF-LIFE
dc.description.keywords EARLY BREAST-CANCER
dc.description.keywords PATIENTS PREFERENCES
dc.description.keywords HEALTH STATES
dc.description.keywords PATIENT PREFERENCES
dc.description.keywords CHOICE EXPERIMENTS
dc.description.keywords DECISION-MAKING
dc.description.keywords OUTCOMES
dc.description.keywords UTILITIES
dc.description.keywords RADIOTHERAPY
dc.description.keywords Science & Technology
dc.description.keywords Life Sciences & Biomedicine
dc.description.keywords Oncology
dc.description.keywords ONCOLOGY
dc.description.keywords prostate cancer
dc.description.keywords preferences
dc.description.keywords trade-off
dc.description.keywords utility
dc.description.keywords survival benefit
dc.description.keywords quality of life
dc.description.keywords QUALITY-OF-LIFE
dc.description.keywords EARLY BREAST-CANCER
dc.description.keywords PATIENTS PREFERENCES
dc.description.keywords HEALTH STATES
dc.description.keywords PATIENT PREFERENCES
dc.description.keywords CHOICE EXPERIMENTS
dc.description.keywords DECISION-MAKING
dc.description.keywords OUTCOMES
dc.description.keywords UTILITIES
dc.description.keywords RADIOTHERAPY
dc.description.keywords Science & Technology
dc.description.keywords Life Sciences & Biomedicine
dc.description.keywords Oncology
dc.description.keywords ONCOLOGY
dc.description.keywords prostate cancer
dc.description.keywords preferences
dc.description.keywords trade-off
dc.description.keywords utility
dc.description.keywords survival benefit
dc.description.keywords quality of life
dc.description.keywords QUALITY-OF-LIFE
dc.description.keywords EARLY BREAST-CANCER
dc.description.keywords PATIENTS PREFERENCES
dc.description.keywords HEALTH STATES
dc.description.keywords PATIENT PREFERENCES
dc.description.keywords CHOICE EXPERIMENTS
dc.description.keywords DECISION-MAKING
dc.description.keywords OUTCOMES
dc.description.keywords UTILITIES
dc.description.keywords RADIOTHERAPY
pubs.embargo.period Not known
pubs.organisational-group /University of Technology Sydney
pubs.organisational-group /University of Technology Sydney/Faculty of Business
pubs.organisational-group /University of Technology Sydney/Faculty of Business/Economics
pubs.organisational-group /University of Technology Sydney/Faculty of Science
pubs.organisational-group /University of Technology Sydney/Faculty of Science/School of Mathematical Sciences
pubs.organisational-group /University of Technology Sydney/Strength - Health Economics and Research Evaluation
pubs.organisational-group /University of Technology Sydney/Strength - Study of Choice


Files in this item

This item appears in the following Collection(s)

Show simple item record